Home Newsfeeds Arcturus Therapeutics Reports Phase 1b Data for Cystic Fibrosis Treatment

News

Arcturus Therapeutics Reports Phase 1b Data for Cystic Fibrosis Treatment

Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program Business Wire Arcturus to present new Phase 1b interim data for ARCT-032 at European Cystic Fibrosis Conference on June 7, 2024 First

byBenzinga Newsdesk

May 28, 2024

1 minute read

Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program

Business Wire

Arcturus to present new Phase 1b interim data for ARCT-032 at European Cystic Fibrosis Conference on June 7, 2024

First four CF patients demonstrated an average improvement of 4% FEV1 after two administrations

Arcturus Therapeutics Holdings Inc. ((the “Company”, “Arcturus”, NASDAQ:ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, today announced Arcturus will be presenting Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032, an inhaled investigational mRNA therapeutic to treat CF, at the 47th European Cystic Fibrosis Conference on June 7, 2024.

Fund Managers Share Top Dividend Stock Picks For Passive Income Stream — Here’s What They Suggest

By Benzinga Neuro

April 10, 5:01 AM

Three dividend stocks have been singled out by fund managers as potential sources of attractive yields and growth, thereby offering a reliable stream of passive income.

AVGO

LogicMark, Inc. Postpones Release Of Q4 And FY23 Financial Results; Filing An Extension With The SEC To Allow For More Time To Complete Its 2023 Annual Report On Form 10-K

By Benzinga Newsdesk

April 1, 4:07 PM

LogicMark, Inc. (NASDAQ:LGMK), a provider of personal emergency response systems, health communications devices, and technology for the growing care economy, today announced that it has postponed the release of

LGMK

Global Markets Today While US Was Sleeping

By Akanksha Bakshi

July 26, 6:15 AM

On Tuesday, July 25, the U.S. markets closed higher, with the Dow Jones maintaining its winning streak. Feds Interest rate decision awaited, with most market participants expecting a 25 basis-point rate hike.

EEMA

Bitcoin, Ethereum, Dogecoin Mixed On Fed Anxieties: Analyst Thinks Wall Street Risk Aversion Could Revive Apex Crypto

By Mehab Qureshi

February 23, 10:49 PM

Major coins traded mixed on Thursday late evening, as the market capitalization declined by 0.20% in the last 24 hours to $1.10 trillion, recorded at 8:30 p.m. EST.

$DOGE